Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Magazines
Fall Home Improvements
Women
Home & Realty
Outdoor Guide
Premier Home Style Tour 2024
Spring Home & Garden Show
Spring on the Road
Spring Wellness
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
Parcel Pickup
2024 Readersâ Choice
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Biodexa Pharmaceuticals plc - American Depositary Shares
(NQ:
BDRX
)
5.990
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EST, Dec 4, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Biodexa Pharmaceuticals plc - American Depositary Shares
< Previous
1
2
3
4
5
6
Next >
12 Health Care Stocks Moving In Thursday's Pre-Market Session
November 21, 2024
Via
Benzinga
Gaining Momentum, Biodexa is Advancing Two Recent Acquisitions Through the Clinic
November 21, 2024
Via
ACCESSWIRE
BDRX INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation Into Biodexa Pharmaceuticals Plc and Encourages Investors to Contact the Firm
October 28, 2024
From
Bronstein, Gewirtz & Grossman, LLC
Via
Business Wire
BDRX INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation Into Biodexa Pharmaceuticals Plc and Encourages Investors to Contact the Firm
October 20, 2024
From
Bronstein, Gewirtz & Grossman, LLC
Via
Business Wire
Biodexa's MX-110 Continues to Show Promise in Recurrent Glioblastoma (rGBM), the Deadliest Brain Cancer
October 17, 2024
Via
ACCESSWIRE
How Is The Market Feeling About Biodexa Pharmaceuticals?
July 16, 2024
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
October 17, 2024
Via
Benzinga
Why Is Brain Cancer-Focused Biodexa Pharmaceuticals Stock Trading Lower On Thursday?
October 17, 2024
Biodexa Pharmaceuticals reports updates from the MAGIC-1 study on MTX110 for recurrent glioblastoma. MTX110 has also demonstrated potential in treating diffuse midline glioma, a rare brain cancer, with...
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
October 17, 2024
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
October 16, 2024
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
October 16, 2024
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
October 16, 2024
Via
Benzinga
Biodexa Pharmaceuticals Stock Is Soaring After The Close: What's Driving Shares Higher?
October 15, 2024
Biodexa Pharmaceuticals shares are soaring in Tuesday's after-hours session after the company announced it was granted an extension to demonstrate compliance with Nasdaq listing requirements.
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
October 15, 2024
Via
Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
September 02, 2024
Via
Benzinga
Why ASP Isotopes Shares Are Trading Lower By 9%? Here Are Other Stocks Moving In Friday's Mid-Day Session
July 12, 2024
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
July 12, 2024
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
Via
InvestorPlace
Why Ericsson Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket
July 12, 2024
Via
Benzinga
Gold Rises Sharply; Methode Electronics Shares Spike Higher
July 11, 2024
Via
Benzinga
Why ConAgra Brands Shares Are Trading Lower? Here Are Other Stocks Moving In Thursday's Mid-Day Session
July 11, 2024
Via
Benzinga
JOBY Stock Pops After Completing 523-Mile eVTOL Flight
July 11, 2024
Joby Aviation stock is flying higher on Thursday after the eVTOL company reported a new milestone for a hydrogen-electric aircraft.
Via
InvestorPlace
Cancer-Focused Nano-Cap Biodexa Pharmaceuticals Stock Is Surging On Thursday - Here's Why
July 11, 2024
Biodexa Pharmaceuticals shares surge following phase 2 trial results for eRapa, a potential treatment for Familial Adenomatous Polyposis. The study showed a 17% median reduction in polyp burden and a...
Via
Benzinga
KZIA Stock Alert: Kazia Continues Its Surge on Thursday With 51% Gains
July 11, 2024
Kazia Therapeutics stock is still rallying on Thursday with heavy trading of KZIA alongside its latest positive clinical trial data.
Via
InvestorPlace
Why Is Biodexa Pharmaceuticals (BDRX) Up 56% Today?
July 11, 2024
Biodexa Pharmaceuticals stock is up on Thursday with heavy trading of BDRX shares alongside positive clinical trial news.
Via
InvestorPlace
Nasdaq Dips Over 300 Points; PepsiCo Reports Weak Sales
July 11, 2024
Via
Benzinga
US Stocks Edge Higher; Inflation Slows To 3% In June
July 11, 2024
Via
Benzinga
Topics
Economy
Exposures
Interest Rates
Biodexa Announces Additional Positive Results Of Phase 2 Trial Of eRapa in Treatment Of Precancerous Polyps in the GI Tract - Now 12-Month Data
July 11, 2024
Via
ACCESSWIRE
Promising Phase 2 Results For Biodexa's eRapa(TM) Indicates Hope for FAP Patients Who Otherwise Have a 100% Lifetime Risk of Colorectal Cancer
June 03, 2024
Via
ACCESSWIRE
12 Health Care Stocks Moving In Tuesday's After-Market Session
May 28, 2024
Via
Benzinga
Nasdaq Falls Over 100 Points; TJX Posts Upbeat Q1 Results
May 22, 2024
Via
Benzinga
< Previous
1
2
3
4
5
6
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.